FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2986814662> ?p ?o ?g. }

• W2986814662 endingPage "9" @default.
• W2986814662 startingPage "1" @default.
• W2986814662 abstract "Regulatory agencies require the assessment of cardiovascular (CV) safety for new type 2 diabetes (T2D) therapies through CV outcome trials (CVOTs). However, patients included in CVOTs assessing sodium-glucose cotransporter-2 inhibitors (SGLT2i) might not be representative of those seen in clinical practice. This study examined the proportion of patients that would have been enrolled into three main SGLT2i CVOTs to determine whether these trials' eligibility criteria can be applied to a real-world Mediterranean T2D population.Cross-sectional, retrospective, cohort study of T2D patients registered in primary care centres of the Catalan Institute of Health using medical records from a population database (SIDIAP) that includes approximately 74% of the population in Catalonia (Spain). Eligibility criteria were according to those of three SGLT2i CVOTs: EMPA-REG OUTCOME (empagliflozin), CANVAS (canagliflozin), and DECLARE-TIMI 58 (dapagliflozin).By the end of 2016, the database included 373,185 patients with T2D with a mean age of 70 ± 12 years, 54.9% male, with a mean duration of T2D of 9 ± 6 years, and a mean glycated haemoglobin (HbA1c) of 7.12% ± 1.32 (59% with HbA1c < 7%). Of these, 86,534 (23%) had established CV disease and 28% chronic renal failure (estimated glomerular filtration < 60 ml/min/1.73m2). Among all included patients, only 8.2% would have qualified for enrolment into the EMPA-REG OUTCOME trial, 29.6% into the CANVAS program, and 38% into the DECLARE-TIMI 58 trial. The main limiting factors for inclusion would have been a previous history of CV disease and the baseline HbA1c value.The external validity of the analysed CVOTs is clearly limited when applying the same eligibility criteria to a T2D Mediterranean population." @default.
• W2986814662 created "2019-11-22" @default.
• W2986814662 creator A5012040554 @default.
• W2986814662 creator A5012291664 @default.
• W2986814662 creator A5014656891 @default.
• W2986814662 creator A5021845200 @default.
• W2986814662 creator A5026095985 @default.
• W2986814662 creator A5034010147 @default.
• W2986814662 creator A5049181124 @default.
• W2986814662 date "2019-11-11" @default.
• W2986814662 modified "2023-10-12" @default.
• W2986814662 title "How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area" @default.
• W2986814662 cites W1526927233 @default.
• W2986814662 cites W1752094483 @default.
• W2986814662 cites W2015712245 @default.
• W2986814662 cites W2035433295 @default.
• W2986814662 cites W2059121073 @default.
• W2986814662 cites W2063942209 @default.
• W2986814662 cites W2123946565 @default.
• W2986814662 cites W2132425160 @default.
• W2986814662 cites W2133980496 @default.
• W2986814662 cites W2139171405 @default.
• W2986814662 cites W2146264128 @default.
• W2986814662 cites W2147663252 @default.
• W2986814662 cites W2150959326 @default.
• W2986814662 cites W2301210108 @default.
• W2986814662 cites W2424539745 @default.
• W2986814662 cites W2512833448 @default.
• W2986814662 cites W2581368499 @default.
• W2986814662 cites W2626446274 @default.
• W2986814662 cites W2726236139 @default.
• W2986814662 cites W2744723725 @default.
• W2986814662 cites W2745253866 @default.
• W2986814662 cites W2746874591 @default.
• W2986814662 cites W2750917994 @default.
• W2986814662 cites W2754469738 @default.
• W2986814662 cites W2754689471 @default.
• W2986814662 cites W2772844083 @default.
• W2986814662 cites W2793355388 @default.
• W2986814662 cites W2806521060 @default.
• W2986814662 cites W2808915250 @default.
• W2986814662 cites W2884961588 @default.
• W2986814662 cites W2894993577 @default.
• W2986814662 cites W2899764361 @default.
• W2986814662 cites W2900413769 @default.
• W2986814662 cites W2903720206 @default.
• W2986814662 cites W2912146044 @default.
• W2986814662 cites W2916296804 @default.
• W2986814662 cites W2999223678 @default.
• W2986814662 cites W2953055087 @default.
• W2986814662 doi "https://doi.org/10.1155/2019/2018374" @default.
• W2986814662 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6877986" @default.
• W2986814662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31815146" @default.
• W2986814662 hasPublicationYear "2019" @default.
• W2986814662 type Work @default.
• W2986814662 sameAs 2986814662 @default.
• W2986814662 citedByCount "12" @default.
• W2986814662 countsByYear W29868146622020 @default.
• W2986814662 countsByYear W29868146622021 @default.
• W2986814662 countsByYear W29868146622022 @default.
• W2986814662 countsByYear W29868146622023 @default.
• W2986814662 crossrefType "journal-article" @default.
• W2986814662 hasAuthorship W2986814662A5012040554 @default.
• W2986814662 hasAuthorship W2986814662A5012291664 @default.
• W2986814662 hasAuthorship W2986814662A5014656891 @default.
• W2986814662 hasAuthorship W2986814662A5021845200 @default.
• W2986814662 hasAuthorship W2986814662A5026095985 @default.
• W2986814662 hasAuthorship W2986814662A5034010147 @default.
• W2986814662 hasAuthorship W2986814662A5049181124 @default.
• W2986814662 hasBestOaLocation W29868146621 @default.
• W2986814662 hasConcept C126322002 @default.
• W2986814662 hasConcept C134018914 @default.
• W2986814662 hasConcept C2775887513 @default.
• W2986814662 hasConcept C2777180221 @default.
• W2986814662 hasConcept C2777422806 @default.
• W2986814662 hasConcept C2908647359 @default.
• W2986814662 hasConcept C555293320 @default.
• W2986814662 hasConcept C71924100 @default.
• W2986814662 hasConcept C99454951 @default.
• W2986814662 hasConceptScore W2986814662C126322002 @default.
• W2986814662 hasConceptScore W2986814662C134018914 @default.
• W2986814662 hasConceptScore W2986814662C2775887513 @default.
• W2986814662 hasConceptScore W2986814662C2777180221 @default.
• W2986814662 hasConceptScore W2986814662C2777422806 @default.
• W2986814662 hasConceptScore W2986814662C2908647359 @default.
• W2986814662 hasConceptScore W2986814662C555293320 @default.
• W2986814662 hasConceptScore W2986814662C71924100 @default.
• W2986814662 hasConceptScore W2986814662C99454951 @default.
• W2986814662 hasFunder F4320334923 @default.
• W2986814662 hasLocation W29868146621 @default.
• W2986814662 hasLocation W29868146622 @default.
• W2986814662 hasLocation W29868146623 @default.
• W2986814662 hasLocation W29868146624 @default.
• W2986814662 hasLocation W29868146625 @default.
• W2986814662 hasOpenAccess W2986814662 @default.
• W2986814662 hasPrimaryLocation W29868146621 @default.
• W2986814662 hasRelatedWork W2151345870 @default.
• W2986814662 hasRelatedWork W2199901734 @default.

• next